A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Lenacapavir, created by Foster City-based Gilead Sciences, has been in use for several years as a treatment for HIV/AIDS ...

In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...

Last week the US Food and Drug Administration approved Gilead Sciences Yeztugo (lenacapavir) for the prevention of HIV ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...

Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.

Stay informed on health matters with Zubeda Hamid's newsletter covering cataract surgeries, maternal health, and medical ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

Explore how moderate mobile gaming benefits mental and cognitive health, despite risks of addiction, with insights from ...